Have a personal or library account? Click to login
Normality assessment, few paradigms and use cases Cover
Open Access
|Jul 2022

Abstract

Background: The importance of applying the normality tests is underlined by the way of continuing the statistical protocol for numerical data within inferential statistics, respectively by the parametric or non-parametric tests that we will apply further on.

Methods: To check the calculation mode, we used sets of random values and we performed the normality assessment using statistical calculation programs. We took non-Gaussian data (n = 30, n = 50, n = 100, n = 500) and Gaussian data (n = 30, n = 50, n = 100, n = 500) for which we checked the normality of the data. Data chosen for this study were most representative for each batch (n).

Results: The application of normality tests to the data under study confirms that the data are non-Gaussian for the first data set. For the Gaussian data sample, the verification of normality is confirmed by the results.

Conclusion: For data up to 50 subjects, it is recommended to apply the Shapiro-Wilk test, but also to apply graphical methods to confirm the accuracy of the result. If the data samples have more than 50 values, the D’Agostino & Pearson omnibus normality test should be applied and if the statistical program does not contain this test, the Shapiro-Wilk test can be applied (in the case of SPSS). Graphical methods, although they require some experience, are useful for identifying the normality of distributions with a small number of data.

DOI: https://doi.org/10.2478/rrlm-2022-0030 | Journal eISSN: 2284-5623 | Journal ISSN: 1841-6624
Language: English
Page range: 251 - 260
Submitted on: May 26, 2022
Accepted on: Jun 16, 2022
Published on: Jul 18, 2022
Published by: Romanian Association of Laboratory Medicine
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2022 Călin Avram, Marius Mărușteri, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons Attribution 4.0 License.